CN105394756A - Compound herba silybi orally disintegrating tablet and preparation method thereof - Google Patents
Compound herba silybi orally disintegrating tablet and preparation method thereof Download PDFInfo
- Publication number
- CN105394756A CN105394756A CN201510854555.7A CN201510854555A CN105394756A CN 105394756 A CN105394756 A CN 105394756A CN 201510854555 A CN201510854555 A CN 201510854555A CN 105394756 A CN105394756 A CN 105394756A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- milk thistle
- disintegrating tablet
- weight
- oral disintegrating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 89
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000006191 orally-disintegrating tablet Substances 0.000 title abstract 6
- 235000012907 honey Nutrition 0.000 claims abstract description 42
- 241001116389 Aloe Species 0.000 claims abstract description 34
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 34
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 34
- 241000241413 Propolis Species 0.000 claims abstract description 30
- 229940069949 propolis Drugs 0.000 claims abstract description 30
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 29
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 29
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 12
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 12
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241000320380 Silybum Species 0.000 claims description 139
- 235000010841 Silybum marianum Nutrition 0.000 claims description 138
- 244000163122 Curcuma domestica Species 0.000 claims description 36
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 36
- 235000003373 curcuma longa Nutrition 0.000 claims description 36
- 239000000463 material Substances 0.000 claims description 36
- 235000013976 turmeric Nutrition 0.000 claims description 36
- 239000006071 cream Substances 0.000 claims description 33
- 239000002504 physiological saline solution Substances 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 25
- 241000245665 Taraxacum Species 0.000 claims description 23
- 230000018044 dehydration Effects 0.000 claims description 22
- 238000006297 dehydration reaction Methods 0.000 claims description 22
- 239000002131 composite material Substances 0.000 claims description 21
- 239000013078 crystal Substances 0.000 claims description 20
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 241000132536 Cirsium Species 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 17
- 239000003643 water by type Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 11
- 241000202807 Glycyrrhiza Species 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 239000002893 slag Substances 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- 230000000694 effects Effects 0.000 abstract description 22
- 230000036541 health Effects 0.000 abstract description 4
- 208000019423 liver disease Diseases 0.000 abstract description 3
- 230000000050 nutritive effect Effects 0.000 abstract description 3
- 239000002932 luster Substances 0.000 abstract description 2
- 229930014626 natural product Natural products 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 20
- 208000006454 hepatitis Diseases 0.000 description 8
- 231100000283 hepatitis Toxicity 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000002279 cholagogic effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 241000189115 Catananche Species 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001625909 Eremurus chinensis Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000904014 Pappus Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 210000003459 common hepatic duct Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a compound herba silybi orally disintegrating tablet. The compound herba silybi orally disintegrating tablet is prepared from, by weight, 20-28 parts of herba silybi honey, 30-35 parts of herba silybi pollen, 33-40 parts of microcrystalline cellulose, 1-5 parts of water soluble propolis, 1-5 parts of normal saline, 0.5-3 parts of rhizoma curcumae longae, 0.5-2 parts of dandelions, 1-1.5 parts of aloe and 1-2 parts of licorice roots. The invention further discloses a preparation method of the compound herba silybi orally disintegrating tablet. According to the compound herba silybi orally disintegrating tablet and the preparation method thereof, dosing is reasonable, good nutritive value and liver-protecting effect are achieved, and particularly for convalescent patients with hepatopathy, a good rehabilitation effect is achieved. The state is stable, the layering phenomenon does not occur, the taste is good, the preparation temperature is not high, the color and luster can be ensured to be unchanged, and light yellow is achieved. The compound herba silybi orally disintegrating tablet is free of preservative, is a healthy, green and pure natural product and is beneficial for body health of a user.
Description
Technical field
The present invention relates to edible health care product, particularly a kind of compound milk thistle oral disintegrating tablet, the invention still further relates to the preparation method of this compound milk thistle oral disintegrating tablet.
Background technology
Silybum 1 year or biennial catananche, be excellent protect liver plant, originate in West Europe and north African.China in Shaanxi, Gansu, Heilungkiang and Hebei etc. economize cultivation, its strong adaptability, tight to soil, moisture requirement, ground, sandy beach, salt-soda soil all can be planted.Herb is used for early stage of pyogenic infection of skin and erysipelas; Fruit and extract are used for hepatopathy, spleen sick gall stone, jaundice and chronic cough.Clearing heat and detoxicating, to protect the liver, cholagogic, protect brain, anti-X-ray.All there is good efficacy to liver, the scorching diseases of courage such as inflammation around acute or chronic hepatitis, cirrhosis, fatty liver, metabolism toxic liver injury, cholelithiasis, cholangitis and hepatic duct, hepatopathy patient subjective symptoms and some biochemical index can be made as serum bilirubin, improvement rapidly such as white Anhui and ball Anhui coefficient, prothrombing, glutamic-pyruvic transaminase etc.Milk thistle honey as the highly finished product of the glucide of milk thistle, have hypotensive, protect the effect such as liver, alleviating pain, be not only delicious nutriment, and the medicine being treatment various diseases, strong health and promoting longevity.Milk thistle honey is also useful especially with the children being easy to the food digested for somagenic need high heat, and it can promote appetite, improves metabolism, people's spirit is good for refreshing and full of physical strength, improves body to the resistance of disease.Milk thistle pollen, as the excellent product of a kind of milk thistle shape, also has suitable effect.Water-soluble propolis can be absorbed better by human body, improves health-care effect.
Turmeric is the rhizome of zingiberaceous plant turmeric, and turmeric is pungent, bitter, and temperature, return spleen, Liver Channel, turmeric can break blood gas, inducing meastruation to relieve menalgia.Turmeric is used for the chest side of body and twinges, amenorrhoea, abdominal mass, rheumatism shoulder arm pain, tumbling and swelling.Further, turmeric has the effects such as reducing blood lipid, antitumor action, anti-inflammatory and cholagogic.
Dandelion composite family herbaceos perennial.Capitulum, the bobbles that on seed, adularescent pappus is formed, new life is bred in the new place that racks after the flowers are in blossom.Containing multiple health-nutrition compositions such as taraxol, taraxacin, choline, organic acid, synanthrin in dandelion plant, there are the effects such as diuresis, laxative, removing jaundice subcutaneous ulcer, cholagogic.Dandelion, simultaneously containing protein, fat, carbohydrate, trace element and vitamin etc., has abundant nutritive value, raw-eaten, stir-fry and eat, cook soup, is the plant of dietotherapeutic.Dandelion has abundant carrotene and vC and mineral matter, to the effect that indigestion, constipation are all improved.
Aloe originates in Mediterranean, Africa, is Eremurus chinensis section herbaceos perennial, is to integrate edible, medicinal, improve looks, view and admire plant nova, has the effects such as sterilization, anti-inflammatory, immunity and removing toxic substances.Modern study shows, its leaf containing aloe-emodin, different aloe-emodin and aloe bitter principle etc., pharmacological evaluation have rush down under, antitumaous effect.Chinese aloe flower is cold in nature, bitter and puckery flavor, has heat-clearing, cough-relieving, hemostasia effect, can treat cough, spit blood.
The many growths of Radix Glycyrrhizae, in arid, semiarid desert steppe, desert edge and loess hill area, are also easy to breeding, its strong adaptability, strong stress resistance in the field and flood land of irrigation areas.In China, growth of Glycyrrhiza uralensis is on the ground such as northwest, North, Northeast China.Radix Glycyrrhizae taste is sweet, and property is gentle, enters the heart, spleen, lung, stomach four warp.Raw with cooler, can purging intense heat and detonicating, relieving spasm to stop pain; Process with partially warm, can fall apart exterior cold, tonifying middle-Jiao and Qi.In addition, Radix Glycyrrhizae is also good at being in harmonious proportion the property of medicine, separates the poison of hundred medicines.
Above material not only can eat as health products at ordinary times, also can use as medicinal material, when jointly eating or use, more can mutually promote.Oral disintegrating tablet is as a kind of new formulation, and have and absorb fast, bioavilability is high, and enteron aisle is residual few, and side effect is low and can avoid the remarkable advantage such as first pass effect of liver.Therefore, research and develop and a kind ofly become a urgent and important job containing the compound milk thistle oral disintegrating tablet of above-mentioned material and a kind of preparation method of compound milk thistle oral disintegrating tablet.
Summary of the invention
The first object of the present invention is the weak point overcoming above-mentioned existing background technology, and provides a kind of compound milk thistle oral disintegrating tablet.
The second object of the present invention is the preparation method providing this compound milk thistle oral disintegrating tablet.
The first object of the present invention is reached by following measure: a kind of compound milk thistle oral disintegrating tablet, flies thistle powder, 33 ~ 40 weight portion microcrystalline celluloses, the water-soluble propolis of 1 ~ 5 weight portion, 1 ~ 5 weight portion physiological saline, 0.5 ~ 3 weight portion turmeric, 0.5 ~ 2 weight portion dandelion, 1 ~ 1.5 weight portion aloe, 1 ~ 2 weight portion Radix Glycyrrhizae form by 20 ~ 28 weight portion milk thistle honey, 30 ~ 35 weight parts waters.
Preferably, fly thistle powder by 21 ~ 25 weight portion milk thistle honey, 33 ~ 35 weight parts waters, 33 ~ 35 weight portion microcrystalline celluloses, the water-soluble propolis of 1 ~ 3 weight portion, 1 ~ 3 weight portion physiological saline, 0.5 ~ 2 weight portion turmeric, 0.5 ~ 1.5 weight portion dandelion, 1.2 ~ 1.5 weight portion aloes, 1 ~ 1.5 weight portion Radix Glycyrrhizae form.
Further, the weight ratio of turmeric, dandelion, aloe, Radix Glycyrrhizae is 1:1:1:1.
Further, fly thistle powder by 23 weight portion milk thistle honey, 35 weight parts waters, 34 weight portion microcrystalline celluloses, the water-soluble propolis of 2 weight portion, 3 weight portion physiological saline, 1.5 weight portion turmerics, 1.5 weight portion dandelions, 1.5 weight portion aloes, 1.5 weight portion Radix Glycyrrhizaes form.
The second object of the present invention is reached by following measure: the method preparing above-mentioned compound milk thistle oral disintegrating tablet, comprises the steps:
1) heating in iron pan that turmeric, dandelion, aloe, Radix Glycyrrhizae added water by weight is boiled and is boiled 7 hours one-tenth pastel, and remove slag, be dried into crystalline solid, cooling, obtains composite crystal;
2) by weight by the milk thistle pollen ground, physiological saline, water-soluble propolis and step 1) the composite crystal of gained mixes, places 12 ~ 18h, obtain mixed material at 25 ~ 35 DEG C;
3) the milk thistle honey of weight portion is added step 2) mixed material of gained, mix, at 40 ~ 50 DEG C, place 5 ~ 8h;
4) by step 3) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
5) by weight in step 4) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
6) with tablet press machine by step 5) dehydration after compound milk thistle cream make cylindrical oral disintegrating tablet, obtain compound milk thistle oral disintegrating tablet.
Preferably, step 2) in, at 30 ~ 35 DEG C, place 15h.
Further, step 3) in, at 45 DEG C, place 8h.
The invention has the advantages that:
One, reasonable mixture ratio, has good nutritive value and protects liver effect, especially to convalescent hepatopath, having good rehabilitative action;
Its two, in stable condition, without lamination, mouthfeel is good, and preparation temperature is not high, can ensure that color and luster does not change, for light yellow;
Its three, do not add anticorrisive agent, be a kind of healthy green pure natural product, be of value to the healthy of user.
They are four years old, the present invention sums up in the bee product dietotherapy operation of nearly 20 years, and long-term eating can strengthen body immunity, and has certain opsonic action to hepatopath, because raw material of the present invention is natural prodcuts, except pollen hypersensitivity physique person, edible there is no has any bad reaction to human body for a long time.
The every sheet of compound milk thistle oral disintegrating tablet of the present invention 2 grams.Take as the morning and evening is each once, take before the meal.
Detailed description of the invention
Describe performance of the present invention in detail below in conjunction with embodiment, but they do not form limitation of the invention, only for example.Simultaneously by illustrating that advantage of the present invention will become clearly and easy understand.
A kind of compound milk thistle oral disintegrating tablet, flies thistle powder by 20 ~ 28 weight portion milk thistle honey, 30 ~ 35 weight parts waters, 33 ~ 40 weight portion microcrystalline celluloses, the water-soluble propolis of 1 ~ 5 weight portion, 1 ~ 5 weight portion physiological saline, 0.5 ~ 3 weight portion turmeric, 0.5 ~ 2 weight portion dandelion, 1 ~ 1.5 weight portion aloe, 1 ~ 2 weight portion Radix Glycyrrhizae forms.
Preferably, fly thistle powder by 21 ~ 25 weight portion milk thistle honey, 33 ~ 35 weight parts waters, 33 ~ 35 weight portion microcrystalline celluloses, the water-soluble propolis of 1 ~ 3 weight portion, 1 ~ 3 weight portion physiological saline, 0.5 ~ 2 weight portion turmeric, 0.5 ~ 1.5 weight portion dandelion, 1.2 ~ 1.5 weight portion aloes, 1 ~ 1.5 weight portion Radix Glycyrrhizae form.
Further, the weight ratio of turmeric, dandelion, aloe, Radix Glycyrrhizae is 1:1:1:1.
Further, fly thistle powder by 23 weight portion milk thistle honey, 35 weight parts waters, 34 weight portion microcrystalline celluloses, the water-soluble propolis of 2 weight portion, 3 weight portion physiological saline, 1.5 weight portion turmerics, 1.5 weight portion dandelions, 1.5 weight portion aloes, 1.5 weight portion Radix Glycyrrhizaes form.
Prepare the method for above-mentioned compound milk thistle oral disintegrating tablet, comprise the steps:
1) heating in iron pan that turmeric, dandelion, aloe, Radix Glycyrrhizae added water by weight is boiled and is boiled 7 hours one-tenth pastel, and remove slag, be dried into crystalline solid, cooling, obtains composite crystal;
2) by weight by the milk thistle pollen ground, physiological saline, water-soluble propolis and step 1) the composite crystal of gained mixes, places 12 ~ 18h, obtain mixed material at 25 ~ 35 DEG C;
3) the milk thistle honey of weight portion is added step 2) mixed material of gained, mix, at 40 ~ 50 DEG C, place 5 ~ 8h;
4) by step 3) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
5) by weight in step 4) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
6) with tablet press machine by step 5) dehydration after compound milk thistle cream make cylindrical oral disintegrating tablet, obtain compound milk thistle oral disintegrating tablet.
Preferably, step 2) in, at 30 ~ 35 DEG C, place 15h.
Further, step 3) in, at 45 DEG C, place 8h.
Embodiment 1
Compound milk thistle oral disintegrating tablet, flies thistle powder by 23 weight portion milk thistle honey, 35 weight parts waters, 34 weight portion microcrystalline celluloses, the water-soluble propolis of 2 weight portion, 3 weight portion physiological saline, 1.5 weight portion turmerics, 1.5 weight portion dandelions, 1.5 weight portion aloes, 1.5 weight portion Radix Glycyrrhizaes forms.
Prepare the method for above-mentioned compound milk thistle oral disintegrating tablet, comprise the steps:
1) heating in iron pan that turmeric, dandelion, aloe, Radix Glycyrrhizae added water by weight is boiled and is boiled 7 hours one-tenth pastel, and remove slag, be dried into crystalline solid, cooling, obtains composite crystal;
2) by weight by the milk thistle pollen ground, physiological saline, water-soluble propolis and step 1) the composite crystal of gained mixes, places 15h, obtain mixed material at 35 DEG C;
3) the milk thistle honey of weight portion is added step 2) mixed material of gained, mix, at 45 DEG C, place 8h;
4) by step 3) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
5) by weight in step 4) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
6) with tablet press machine by step 5) dehydration after compound milk thistle cream make cylindrical oral disintegrating tablet, obtain compound milk thistle oral disintegrating tablet.
Embodiment 2
Compound milk thistle oral disintegrating tablet, flies thistle powder by 28 weight portion milk thistle honey, 30 weight parts waters, 35 weight portion microcrystalline celluloses, the water-soluble propolis of 1 weight portion, 2 weight portion physiological saline, 1.3 weight portion turmerics, 1.3 weight portion dandelions, 1.3 weight portion aloes, 1.3 weight portion Radix Glycyrrhizaes forms.
Prepare the method for above-mentioned compound milk thistle oral disintegrating tablet, comprise the steps:
1) heating in iron pan that turmeric, dandelion, aloe, Radix Glycyrrhizae added water by weight is boiled and is boiled 7 hours one-tenth pastel, and remove slag, be dried into crystalline solid, cooling, obtains composite crystal;
2) by weight by the milk thistle pollen ground, physiological saline, water-soluble propolis and step 1) the composite crystal of gained mixes, places 12h, obtain mixed material at 30 DEG C;
3) the milk thistle honey of weight portion is added step 2) mixed material of gained, mix, at 48 DEG C, place 5h;
4) by step 3) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
5) by weight in step 4) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
6) with tablet press machine by step 5) dehydration after compound milk thistle cream make cylindrical oral disintegrating tablet, obtain compound milk thistle oral disintegrating tablet.
Embodiment 3
Compound milk thistle oral disintegrating tablet, flies thistle powder by 28 weight portion milk thistle honey, 30 weight parts waters, 35 weight portion microcrystalline celluloses, the water-soluble propolis of 1 weight portion, 2 weight portion physiological saline, 0.5 weight portion turmeric, 2 weight portion dandelions, 1 weight portion aloe, 2 weight portion Radix Glycyrrhizaes forms.
Prepare the method for above-mentioned compound milk thistle oral disintegrating tablet, comprise the steps:
1) heating in iron pan that turmeric, dandelion, aloe, Radix Glycyrrhizae added water by weight is boiled and is boiled 7 hours one-tenth pastel, and remove slag, be dried into crystalline solid, cooling, obtains composite crystal;
2) by weight by the milk thistle pollen ground, physiological saline, water-soluble propolis and step 1) the composite crystal of gained mixes, places 12h, obtain mixed material at 30 DEG C;
3) the milk thistle honey of weight portion is added step 2) mixed material of gained, mix, at 48 DEG C, place 5h;
4) by step 3) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
5) by weight in step 4) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
6) with tablet press machine by step 5) dehydration after compound milk thistle cream make cylindrical oral disintegrating tablet, obtain compound milk thistle oral disintegrating tablet.
Embodiment 4
Compound milk thistle oral disintegrating tablet, flies thistle powder by 25 weight portion milk thistle honey, 33 weight parts waters, 33 weight portion microcrystalline celluloses, the water-soluble propolis of 3 weight portion, 1 weight portion physiological saline, 3 weight portion turmerics, 0.5 weight portion dandelion, 1.2 weight portion aloes, 1 weight portion Radix Glycyrrhizae forms.
Prepare the method for above-mentioned compound milk thistle oral disintegrating tablet, comprise the steps:
1) heating in iron pan that turmeric, dandelion, aloe, Radix Glycyrrhizae added water by weight is boiled and is boiled 7 hours one-tenth pastel, and remove slag, be dried into crystalline solid, cooling, obtains composite crystal;
2) by weight by the milk thistle pollen ground, physiological saline, water-soluble propolis and step 1) the composite crystal of gained mixes, places 18h, obtain mixed material at 33 DEG C;
3) the milk thistle honey of weight portion is added step 2) mixed material of gained, mix, at 50 DEG C, place 6h;
4) by step 3) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
5) by weight in step 4) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
6) with tablet press machine by step 5) dehydration after compound milk thistle cream make cylindrical oral disintegrating tablet, obtain compound milk thistle oral disintegrating tablet.
Embodiment 5
Compound milk thistle oral disintegrating tablet, flies thistle powder by 20 weight portion milk thistle honey, 32 weight parts waters, 38 weight portion microcrystalline celluloses, the water-soluble propolis of 5 weight portion, 4 weight portion physiological saline, 2 weight portion turmerics, 1 weight portion dandelion, 1.4 weight portion aloes, 1.2 weight portion Radix Glycyrrhizaes forms.
Prepare the method for above-mentioned compound milk thistle oral disintegrating tablet, comprise the steps:
1) heating in iron pan that turmeric, dandelion, aloe, Radix Glycyrrhizae added water by weight is boiled and is boiled 7 hours one-tenth pastel, and remove slag, be dried into crystalline solid, cooling, obtains composite crystal;
2) by weight by the milk thistle pollen ground, physiological saline, water-soluble propolis and step 1) the composite crystal of gained mixes, places 16h, obtain mixed material at 25 DEG C;
3) the milk thistle honey of weight portion is added step 2) mixed material of gained, mix, at 43 DEG C, place 7h;
4) by step 3) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
5) by weight in step 4) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
6) with tablet press machine by step 5) dehydration after compound milk thistle cream make cylindrical oral disintegrating tablet, obtain compound milk thistle oral disintegrating tablet.
Embodiment 6
Compound milk thistle oral disintegrating tablet, flies thistle powder by 21 weight portion milk thistle honey, 31 weight parts waters, 40 weight portion microcrystalline celluloses, the water-soluble propolis of 4 weight portion, 5 weight portion physiological saline, 2.5 weight portion turmerics, 1.3 weight portion dandelions, 1.3 weight portion aloes, 1.8 weight portion Radix Glycyrrhizaes forms.
Prepare the method for above-mentioned compound milk thistle oral disintegrating tablet, comprise the steps:
1) heating in iron pan that turmeric, dandelion, aloe, Radix Glycyrrhizae added water by weight is boiled and is boiled 7 hours one-tenth pastel, and remove slag, be dried into crystalline solid, cooling, obtains composite crystal;
2) by weight by the milk thistle pollen ground, physiological saline, water-soluble propolis and step 1) the composite crystal of gained mixes, places 14h, obtain mixed material at 28 DEG C;
3) the milk thistle honey of weight portion is added step 2) mixed material of gained, mix, at 40 DEG C, place 6.5h;
4) by step 3) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
5) by weight in step 4) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
6) with tablet press machine by step 5) dehydration after compound milk thistle cream make cylindrical oral disintegrating tablet, obtain compound milk thistle oral disintegrating tablet.
Comparative example 1
Contrast compound milk thistle oral disintegrating tablet, flies thistle powder by 23 weight portion milk thistle honey, 35 weight parts waters, 34 weight portion microcrystalline celluloses, the water-soluble propolis of 2 weight portion, 3 weight portion physiological saline, 1.5 weight portion turmerics, 1.5 weight portion dandelions, 1.5 weight portion aloes, 1.5 weight portion Radix Glycyrrhizaes forms.
Prepare the method for above-mentioned compound milk thistle oral disintegrating tablet, comprise the steps:
1) by weight the milk thistle pollen ground, physiological saline, water-soluble propolis are mixed, at 35 DEG C, place 15h, obtain mixed material;
2) the milk thistle honey of weight portion is added step 1) mixed material of gained, mix, at 45 DEG C, place 8h;
3) by step 2) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
4) by weight in step 3) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
5) with tablet press machine by step 4) dehydration after compound milk thistle cream make cylindrical oral disintegrating tablet, obtain compound milk thistle oral disintegrating tablet.
Comparative example 2
Contrast compound milk thistle oral disintegrating tablet, flies thistle powder by 28 weight portion milk thistle honey, 30 weight parts waters, 35 weight portion microcrystalline celluloses, the water-soluble propolis of 1 weight portion, 2 weight portion physiological saline forms.
Prepare the method for above-mentioned compound milk thistle oral disintegrating tablet, comprise the steps:
1) by weight the milk thistle pollen ground, physiological saline, water-soluble propolis are mixed, at 30 DEG C, place 12h, obtain mixed material;
2) the milk thistle honey of weight portion is added step 1) mixed material of gained, mix, at 48 DEG C, place 5h;
3) by step 2) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
4) by weight in step 3) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
5) with tablet press machine by step 4) dehydration after compound milk thistle cream make cylindrical oral disintegrating tablet, obtain compound milk thistle oral disintegrating tablet.
To 500 hepatitis recovery phase patient test, wherein male 282 people, female 218 people, the oldest 65 years old, minimum 27 years old.Take period can not drink, can not maror be eaten, can not greasy food be eaten, must based on light, the hepatitis ill phase is 1 year to 5 years.
Blank is not for take compound milk thistle oral disintegrating tablet Related product, and other respectively take a compound milk thistle oral disintegrating tablet respectively every day sooner or later, and acquired results is as follows:
Table 1 embodiment and comparative example effect
Hepatitis recurrence rate (%) | Evaluate | |
Embodiment 1 | 7.6 | Protect liver effect fine |
Embodiment 2 | 8.3 | Protect liver effect fine |
Embodiment 3 | 11.9 | Protect liver effective |
Embodiment 4 | 19.3 | Protect liver effective |
Embodiment 5 | 16.3 | Protect liver effective |
Embodiment 6 | 14.7 | Protect liver effective |
Comparative example 1 | 25.8 | Protect liver effect general |
Comparative example 2 | 31.3 | Protect liver effect general |
Blank | 50 | - |
In upper table, hepatitis recurrence rate is that less than 10% to be considered as protecting liver effect fine, and it is effective that hepatitis recurrence rate is considered as protecting liver between 10%-20%, and it is general that hepatitis recurrence rate is considered as protecting liver effect lower than 40%.As can be seen from the above table, the compound milk thistle oral disintegrating tablet of composite crystal added containing turmeric, dandelion, aloe, Radix Glycyrrhizae has and better protects liver effect; And in composite crystal, when the weight ratio of turmeric, dandelion, aloe, Radix Glycyrrhizae is 1:1:1:1, the compound milk thistle oral disintegrating tablet of gained to protect liver effect best.
Other is prior art without the part described in detail.
Claims (7)
1. a compound milk thistle oral disintegrating tablet, is characterized in that: fly thistle powder by 20 ~ 28 weight portion milk thistle honey, 30 ~ 35 weight parts waters, 33 ~ 40 weight portion microcrystalline celluloses, the water-soluble propolis of 1 ~ 5 weight portion, 1 ~ 5 weight portion physiological saline, 0.5 ~ 3 weight portion turmeric, 0.5 ~ 2 weight portion dandelion, 1 ~ 1.5 weight portion aloe, 1 ~ 2 weight portion Radix Glycyrrhizae form.
2. compound milk thistle oral disintegrating tablet according to claim 1, is characterized in that: fly thistle powder by 21 ~ 25 weight portion milk thistle honey, 33 ~ 35 weight parts waters, 33 ~ 35 weight portion microcrystalline celluloses, the water-soluble propolis of 1 ~ 3 weight portion, 1 ~ 3 weight portion physiological saline, 0.5 ~ 2 weight portion turmeric, 0.5 ~ 1.5 weight portion dandelion, 1.2 ~ 1.5 weight portion aloes, 1 ~ 1.5 weight portion Radix Glycyrrhizae form.
3. compound milk thistle oral disintegrating tablet according to claim 1, is characterized in that: the weight ratio of described turmeric, dandelion, aloe, Radix Glycyrrhizae is 1:1:1:1.
4. compound milk thistle oral disintegrating tablet according to claim 1, is characterized in that: fly thistle powder by 23 weight portion milk thistle honey, 35 weight parts waters, 34 weight portion microcrystalline celluloses, the water-soluble propolis of 2 weight portion, 3 weight portion physiological saline, 1.5 weight portion turmerics, 1.5 weight portion dandelions, 1.5 weight portion aloes, 1.5 weight portion Radix Glycyrrhizaes form.
5. prepare the method for the compound milk thistle oral disintegrating tablet in claim 1-4 described in arbitrary claim, it is characterized in that, it comprises the steps:
1) heating in iron pan that turmeric, dandelion, aloe, Radix Glycyrrhizae added water by weight is boiled and is boiled 7 hours one-tenth pastel, and remove slag, be dried into crystalline solid, cooling, obtains composite crystal;
2) by weight by the milk thistle pollen ground, physiological saline, water-soluble propolis and step 1) the composite crystal of gained mixes, places 12 ~ 18h, obtain mixed material at 25 ~ 35 DEG C;
3) the milk thistle honey of weight portion is added step 2) mixed material of gained, mix, at 40 ~ 50 DEG C, place 5 ~ 8h;
4) by step 3) mixed material containing milk thistle honey of gained filters, removes particle, obtain compound milk thistle cream;
5) by weight in step 4) add microcrystalline cellulose in the compound milk thistle cream of gained, mix, dehydration;
6) with tablet press machine by step 5) compound milk thistle cream after dehydration makes the cylindrical oral disintegrating tablet of unified specification, obtains compound milk thistle oral disintegrating tablet.
6. the preparation method of compound milk thistle oral disintegrating tablet according to claim 5, is characterized in that: described step 2) in, at 30 ~ 35 DEG C, place 15h.
7. the preparation method of the compound milk thistle oral disintegrating tablet according to claim 5 or 6, is characterized in that: described step 3) in, at 45 DEG C, place 8h.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510854555.7A CN105394756B (en) | 2015-11-29 | 2015-11-29 | Compound milk thistle oral disintegrating tablet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510854555.7A CN105394756B (en) | 2015-11-29 | 2015-11-29 | Compound milk thistle oral disintegrating tablet |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105394756A true CN105394756A (en) | 2016-03-16 |
CN105394756B CN105394756B (en) | 2018-05-11 |
Family
ID=55460803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510854555.7A Active CN105394756B (en) | 2015-11-29 | 2015-11-29 | Compound milk thistle oral disintegrating tablet |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105394756B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108175087A (en) * | 2017-12-25 | 2018-06-19 | 广州美耕食品有限公司 | A kind of turmeric milk thistle pollen of Semen Fagopyri Esculenti piece |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996025056A1 (en) * | 1995-02-15 | 1996-08-22 | Cazaj Jozef | Process for producing a food product based on bee products, and a food product therefrom |
CN1356060A (en) * | 2001-12-12 | 2002-07-03 | 吴军 | Preparation made of aloe, ganoderma, propolis, melissa pollen and honey |
CN101856384A (en) * | 2009-04-09 | 2010-10-13 | 李佳柔 | Liver-protecting combination |
CN103028092A (en) * | 2012-12-28 | 2013-04-10 | 李瀚旻 | Medicine for regulating liver regeneration and preparation method of medicine |
-
2015
- 2015-11-29 CN CN201510854555.7A patent/CN105394756B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996025056A1 (en) * | 1995-02-15 | 1996-08-22 | Cazaj Jozef | Process for producing a food product based on bee products, and a food product therefrom |
CN1356060A (en) * | 2001-12-12 | 2002-07-03 | 吴军 | Preparation made of aloe, ganoderma, propolis, melissa pollen and honey |
CN101856384A (en) * | 2009-04-09 | 2010-10-13 | 李佳柔 | Liver-protecting combination |
CN103028092A (en) * | 2012-12-28 | 2013-04-10 | 李瀚旻 | Medicine for regulating liver regeneration and preparation method of medicine |
Non-Patent Citations (1)
Title |
---|
高申 等: ""新机型-口崩片在花粉生产上的应用"", 《蜂蜜杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108175087A (en) * | 2017-12-25 | 2018-06-19 | 广州美耕食品有限公司 | A kind of turmeric milk thistle pollen of Semen Fagopyri Esculenti piece |
Also Published As
Publication number | Publication date |
---|---|
CN105394756B (en) | 2018-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103859215B (en) | Feed for laying hens in egg producing period and preparation method of feed | |
CN103734547B (en) | Pig feed for promoting growth of piglets and Chinese medicine additive and preparing method of pig feed and Chinese medicine additive | |
CN104082540B (en) | Health-care eggs feed | |
KR101787432B1 (en) | Method for manufacturing oriental medicine composition which improves menorrhagia and dysmenorrhea comprising fermented velvet antler and yeast hydrolysate | |
CN102640929B (en) | Health care composition capable of clearing heat, removing toxicity, protecting liver and dispelling fire | |
CN104338043B (en) | A kind of medicine for improving immunity and preparation method thereof | |
CN105166544A (en) | Pig mixed feed and preparation method thereof | |
CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
CN105476000B (en) | Compound milk thistle pill | |
CN104161194A (en) | Feed used for reducing content of cholesterol in egg | |
CN104082539B (en) | Health-care eggs additive | |
CN105394756B (en) | Compound milk thistle oral disintegrating tablet | |
CN101342331B (en) | Traditional Chinese medicine for treating pulmonitis and upper respiratory tract infection | |
CN104873730A (en) | Traditional Chinese medicine for treating acute mastitis with liver-qi stagnancy | |
CN104922648A (en) | Traditional Chinese medicine composite for treating chicken diarrhea and preparation method thereof | |
CN104667252A (en) | Traditional Chinese medicine for treating acute gastroenteritis | |
CN104116858A (en) | A traditional Chinese medicine for treating pseudomembranous enteritis | |
CN108552432A (en) | A kind of egg feedstuff and preparation method thereof improving laying rate of laying hen | |
CN114344434B (en) | Traditional Chinese medicine composition for treating pulmonary nodules and preparation method thereof | |
CN105582379A (en) | Traditional Chinese medicine composition for treating liver-stomach disharmony and preparation method of traditional Chinese medicine composition | |
CN104983853A (en) | Traditional Chinese medicine for treating chronic gastritis | |
CN115137795A (en) | Weight-losing and slimming traditional Chinese medicine composition and preparation method thereof | |
CN114533835A (en) | Medicine with effects of aroma and dispelling wind and promoting diuresis and preparation method thereof | |
CN104398902A (en) | Deficiency-cold type chronic bronchitis treating preparation for clearing away heat and dispersing lung and preparation method of preparation | |
CN113425801A (en) | Formula of traditional Chinese medicine decoction pieces for treating rheumatism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |